BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6657921)

  • 1. The change in hypoxic and chronically hypoxic cell fraction in murine tumors treated with hyperthermia.
    Urano M; Kahn J
    Radiat Res; 1983 Dec; 96(3):549-59. PubMed ID: 6657921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hyperthermia on reoxygenation during the fractionated radiotherapy of two murine tumors, FSa-II and MCa.
    Nishimura Y; Urano M
    Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):141-8. PubMed ID: 8175421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of hyperglycemia on the tumor response to irradiation given alone or in combination with hyperthermia.
    Urano M; Todoroki T; Kahn J; Okunieff P
    Radiat Res; 1987 Sep; 111(3):488-97. PubMed ID: 3659283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of thermochemotherapy (combined cyclophosphamide and hyperthermia) given at various temperatures with or without glucose administration on a murine fibrosarcoma.
    Urano M; Kim MS; Kahn J; Kenton LA; Li ML
    Cancer Res; 1985 Sep; 45(9):4162-6. PubMed ID: 4028008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing and sequence of hyperthermia in fractionated radiotherapy of a murine fibrosarcoma.
    Nishimura Y; Urano M
    Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):605-11. PubMed ID: 8226155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on fractionated hyperthermia in experimental animals systems III. Uneven daily doses.
    Urano M; Maher J; Kahn J; Montoya V
    Int J Radiat Oncol Biol Phys; 1983 May; 9(5):717-22. PubMed ID: 6853270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on fractionated hyperthermia in experimental animal systems II. Response of murine tumors to two or more doses.
    Urano M; Rice LC; Montoya V
    Int J Radiat Oncol Biol Phys; 1982 Feb; 8(2):227-33. PubMed ID: 7085378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel and hyperthermia: factors that modify thermal enhancement.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    J Surg Oncol; 2004 Oct; 88(1):14-20. PubMed ID: 15384091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relative significance of repopulation and hypoxic clonogens in the fractionated radiotherapy of a mouse tumor.
    Urano M; Nishimura Y; Yaes R
    Radiat Res; 1995 May; 142(2):204-11. PubMed ID: 7724736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperbaric oxygen and radiobiology of a C3H mouse mammary carcinoma.
    Suit HD; Maeda M
    J Natl Cancer Inst; 1967 Oct; 39(4):639-52. PubMed ID: 18623926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction thermochemotherapy increases therapeutic gain factor for the fractionated radiotherapy given to a mouse fibrosarcoma.
    Kuroda M; Urano M; Nishimura Y; Reynolds R
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):411-7. PubMed ID: 9226330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermal enhancement of the effect of ifosfamide against a spontaneous murine fibrosarcoma, FSa-II.
    Kuroda M; Urano M; Reynolds R
    Int J Hyperthermia; 1997; 13(1):125-31. PubMed ID: 9024933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential kinetics of thermal resistance (thermotolerance) between murine normal and tumor tissues.
    Urano M; Kahn J
    Int J Radiat Oncol Biol Phys; 1986 Jan; 12(1):89-93. PubMed ID: 3943996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are hypoxic cells critical for the outcome of fractionated radiotherapy in a slow-growing mouse tumor?
    Urano M; Nishimura Y; Kuroda M; Reynolds R
    Radiother Oncol; 1998 Aug; 48(2):221-8. PubMed ID: 9783896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic gain factors for fractionated radiation treatment of spontaneous murine tumors using fast neutrons, photons plus O2(1) or 3 ATA, or photons plus misonidazole.
    Suit HD; Sedlacek R; Silver G; Hsieh CC; Epp ER; Ngo FQ; Roberts WK; Verhey L
    Radiat Res; 1988 Dec; 116(3):482-502. PubMed ID: 3205910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of additive heat effect in the therapeutic gain factor in combined hyperthermia and radiotherapy: murine tumor response and foot reaction.
    Sougawa M; Urano M
    Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1561-8. PubMed ID: 1938566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction with hyperthermia of tetrachloroplatinum(II)(Nile blue)2 and tetrachloroplatinum(II)(neutral red)2 in EMT6 murine cells and the murine FSaIIC fibrosarcoma.
    Herman TS; Teicher BA; Pfeffer MR; Khandekar VS; Korbut TT
    Cancer Res; 1990 Jul; 50(13):3826-31. PubMed ID: 2354434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene-radiotherapy.
    Urano M; Kuroda M; Reynolds R; Oberley TD; St Clair DK
    Cancer Res; 1995 Jun; 55(12):2490-3. PubMed ID: 7780953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo.
    Herman TS; Teicher BA; Coleman CN
    Cancer Res; 1990 Aug; 50(16):5055-9. PubMed ID: 2379171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.